Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 02/11/2025 12:35:43 PM
Board Marks: 278
Posts Today: 0
Board Views Today: 2077
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
70959
Good information. The "broad spectrum" potential
bandg
12/21/2021 9:14:37 AM
70958
Links:
(2)
farrell
12/21/2021 9:05:24 AM
70956
The multi-identity just wants to soft bash. But
(3)
Drano
12/20/2021 4:29:32 PM
70955
The "Fat Lady" hasn't sung yet on the P2 results
(5)
Kelt
12/20/2021 3:49:14 PM
70954
Brilacidin phase 2 test suggested they did not
(4)
airplaneguy
12/20/2021 3:06:09 PM
70953
With Regeneron's covid antiviral "antibiotic"
(12)
farrell
12/19/2021 12:10:14 AM
70952
IPIX has a distinct advantage over Galera and
(4)
bandg
12/16/2021 1:50:16 PM
70949
Nice soft-bashing. Galera's drug initially failed
(6)
Drano
12/16/2021 2:22:45 AM
70948
Lilly's Mirikizumab for UC. Galera's GC4419 for
(3)
bandg
12/15/2021 8:41:20 PM
70947
This is a fascinating read. it's no wonder that
(6)
Fit007
12/15/2021 8:00:18 AM
70946
GREAT Brilacidin link from another site. True
(5)
petemantx
12/14/2021 8:10:18 PM
70945
Agreed.
bandg
12/14/2021 6:33:15 PM
70944
That's quite the endorsement of B....that alone
(7)
Chemdeps
12/14/2021 5:57:12 PM
70943
Current university article with mention of
(4)
bandg
12/14/2021 5:34:30 PM
70941
Russian State Register of Medicines status,
(1)
crashco
12/13/2021 9:44:42 AM
70936
Thats easy, Drano. Because theres a whole
(10)
scgmck1
12/08/2021 9:50:42 PM
70934
Glad to see that the multi-identities are
(3)
Drano
12/08/2021 4:05:40 PM
70932
Seems logical that they would continue until
(1)
bandg
12/08/2021 3:09:05 PM
70931
hahaha he's having to sign in under several
(3)
Drano
12/08/2021 3:01:18 PM
70930
The big question I have is why multi-identities
(5)
Drano
12/08/2021 1:40:43 PM
70929
So the big question I have is...are doctors still
(3)
Chemdeps
12/08/2021 11:52:36 AM
70928
On what? Whom are you speaking
(2)
scgmck1
12/07/2021 9:28:33 PM
70927
$IPIX ICYMI
(1)
TonyCorvette
12/07/2021 7:38:14 AM
70925
I'd think any compassionate use analysis could
(1)
bandg
12/06/2021 7:03:33 PM
70923
Easy to find as to Remdesivir recommended
(1)
bandg
12/06/2021 5:39:36 PM
70922
Attached is an article I found online just now by
(3)
petemantx
12/06/2021 4:37:43 PM
70920
Pete, I believe the Yahoo author is incorrect
(11)
Mo
12/06/2021 1:24:24 PM
70915
I found this link on another site and what
(5)
petemantx
12/05/2021 9:25:04 AM
70914
I'd be bettinglarge on that one !!
(3)
Kelt
11/30/2021 10:20:53 PM
70912
How amusing that the scum multiple identity
(8)
Drano
11/30/2021 10:02:32 AM
70910
How far will scum go to manipulate stock price?
(5)
Drano
11/30/2021 9:48:44 AM
70909
Polymedix's study of its defensin mimetics
(6)
farrell
11/28/2021 12:20:39 PM
70908
Thanks for posting this. Brilacidin performs
KDPMD
11/27/2021 8:02:16 PM
70907
Russian clinical trial past fraud
djs7
11/27/2021 7:12:48 PM
70906
Attached link quite interesting for a number of
(8)
petemantx
11/27/2021 1:56:52 PM
70905
The purported "AlanC" who just posted is NOT the
(10)
Drano
11/23/2021 1:54:06 PM
70903
I agree Glad to finally hear from you.
(2)
Kelt
11/22/2021 7:56:04 PM
70899
Besides trying to hide the real issues with this
(6)
falcon74
11/18/2021 12:53:47 PM
70898
copy of my PM .. just now .. to another IPIX
(13)
4kids
11/18/2021 11:19:21 AM
70897
As noted previously, trial analysis is "ongoing"
(3)
bandg
11/18/2021 11:03:44 AM
70896
Update out
stocker11
11/18/2021 8:38:53 AM
70895
Innovation Pharmaceuticals Provides Brilacidin
(4)
bettingbig
11/18/2021 8:38:01 AM
70892
"...Florida teacher hospitalized with COVID-19
(2)
farrell
11/16/2021 2:07:28 PM
70891
No way to know that all analysis has been
(5)
bandg
11/16/2021 11:04:31 AM
70890
The CRO is doing/has completed all the data
(3)
petemantx
11/16/2021 10:53:53 AM
70889
Heparin interacts with the main protease of
Boneysteak
11/16/2021 6:23:50 AM
70888
While most of us view them as the elephant in the
(8)
DrTim
11/15/2021 7:45:18 PM
70886
LOL - That's about PAR for the course. Don't know
NotRichYet2
11/15/2021 11:21:58 AM
70885
He's a Big Pharma insider who will continue
(2)
Drano
11/15/2021 11:07:27 AM
70884
Biden nominated Dr. Robert Califf, Cardiologist,
petemantx
11/15/2021 10:52:06 AM
Newer
Older
Recent Articles
Banorte Earns Top Innovation Award for Banking Excellence
Southern Company Boosts Convertible Senior Notes Offering
Sabre Corporation's Senior Secured Notes Offering Analysis
Soapy Joe's Expands Its Reach with 25th Car Wash Location
Shareholder Support Boosts Patagonia Gold's Calcatreu Financing
LeddarTech Announces Workforce Reduction Amid Financial Challenges
Tornado Equipment Expands Employee Incentives with New Stock Options
Transforming Neurodegenerative Disease Research with Path-ND
Investors Brace for Solaris Energy Securities Class Action
Teleflex Incorporated Faces Legal Scrutiny Over Misleading Claims
Open Lending Corporation Securities Class Action Update
New Law Supports Striking Workers with Unemployment Benefits
Ashley Amirkhan Celebrates Jefferson Scholarship Victory
BetPanda.io: Leading the Charge in Crypto Gambling for 2025
Books-A-Million Welcomes Catherine Hogewood as New Counsel
Explore the World with Atlas Ocean Voyages Memorial Day Offers
Manulife's Strategic Move with New Subordinated Debenture
McDonald's Declares Quarterly Cash Dividend for Investors Worldwide
EQT Successfully Completes Major Offering of Waystar Shares
Understanding AI's Energy Demand and Its Future Implications
Investors Urged to Act Amid Class Action Against RKT
EQT Successfully Concludes Stock Offering for Waystar Corp.
Enbridge Inc. Announces Important Series 13 Preferred Shares Update
FDA Committee Backs DARZALEX FASPRO® for High-Risk Myeloma
Partners Value Investments Reports Strong Q1 2025 Results
Ryman Hospitality Secures $625 Million in Senior Notes
ValOre and South Atlantic: Annual Meeting Update on Amalgamation
Partners Value Investments' Strong Q1 2025 Earnings Report
Inventus Mining Unveils Successful Warrant Exercise Program
Tuya Inc. Reports Strong Financial Growth in Q1 2025
FinVolution Group Unveils Impressive Q1 2025 Financial Performance
ZTO Express First Quarter 2025 Results: Volume and Income Surge
Innovative Payment Integrity Solutions by Codoxo Enhance Efficiency
New Study Links Combined Oral Contraceptives to Stroke Risk
New Research Links Oral Contraceptives with Increased Stroke Risk
Roopak Manchanda Joins Medicus IT as EVP of Community Health
Hometown Financial Group's Strategic Acquisition Plan Unveiled
Investor Insights: Understanding Recent Developments at Travere
UroGen Pharma Faces Investor Scrutiny Amid FDA Concerns
Fulgent Genetics Faces Legal Inquiry as Investors React
WePlay Studios Launches POSTNAB Production Open House Event
Texas Instruments Successfully Prices $1.2 Billion in Notes
Celebrating Bobby Bacci: A Leader in Healthcare Innovation
SIG SAUER Celebrates Major Milestone in Army Armament
PBF Energy Announces Participation in Key Industry Events
Emerging Therapies Set to Transform MAC Lung Disease Landscape
NOVAGOLD Reports Successful Election Results from Annual Meeting
Honoring Jennifer A. Wallace: 2025 Graham & Dodd Prize Laureate
Teva Pharmaceutical Industries Upsizes Senior Notes Offering
Sizzle Acquisition Corp. II to Start Trading Class A Shares and Rights